Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TimeToStop trial of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery
2011-005971-18Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carbamazepine, levetiracetam and lamotrigine in epilepsy (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Improvement in neuropsychological outcome measures and Attention. Started Dec 2013; status: terminated.
02
Drugs
carbamazepinelevetiracetamlamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2011-005971-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005971-18.